NorthX Biologics AB


Swedish contract development and manufacturing organization (CDMO) focused on development and GMP manufacturing for advanced biologics. Offers end-to-end CMC support across modalities including recombinant proteins, viral vaccines and vectors, plasmid DNA, cell therapies and extracellular vesicles. Operates multiple sites in Sweden and provides process development, scale-up, analytical testing, aseptic fill & finish and technology transfer services.

Industries

N/A

NorthX Biologics AB


Services

Process development services

Development and optimization of manufacturing processes from early development to clinical and commercial readiness.

Analytical and testing services

Comprehensive analytical testing tailored to biologic modalities to support development and release testing.

Recombinant protein production

Gene-to-protein services including cloning, expression, cell banking and downstream purification across microbial and mammalian systems.

Viral vaccine and viral vector services

End-to-end manufacturing services for viral vaccines, oncolytic viruses and viral vectors across pre-clinical to commercial stages.

Plasmid DNA manufacturing

Production of plasmid DNA suitable for use in DNA vaccines, viral vector production and mRNA workflows from pre-clinical to commercial scales.

Cell therapy manufacturing

Clinical-focused cell therapy manufacturing and delivery services with flexible solutions for different cell types.

View All Services

Expertise Areas

  • Bioprocessing and scale-up
  • CMC development and manufacturing
  • Analytical testing and QC for biologics
  • Recombinant protein production
  • Show More (7)

Key Technologies

  • GMP manufacturing
  • Process development and scale-up
  • Gene cloning and cell bank generation
  • Protein expression and purification
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.